A mixture of conjugates in which each conjugate in the mixture comprises a calcitonin drug coupled to an oligomer that includes a polyalkylene glycol moiety is disclosed. The mixture may lower serum calcium levels in a subject by 10, 15 or even 20 percent or more. Moreover, the mixture may be more effective at surviving an in vitro model of intestinal digestion than non-conjugated calcitonin. Furthermore, the mixture may exhibit a higher bioavailability than non-conjugated calcitonin.

 
Web www.patentalert.com

< Cyclic -amino acid derivatives as inhibitors of matrix metalloproteases and TNF-

< Biaryl heterocyclic compounds and methods of making and using the same

> Prevention of atherosclerosis and restenosis

> Diaminediols for the treatment of Alzheimer's disease

~ 00278